儿童及青少年特殊情况下住院高血糖管理指导建议

2020-10-30 中华糖尿病杂志.2020.12(10):765-771.

为了提高非内分泌专业儿科医师对儿童及青少年住院高血糖的科学管理能力,特制定本专家共识。在住院高血糖管理中,应坚持以不同病情人群为标准的分层血糖管理原则。胰岛素静脉输注和多次皮下注射(如基础‑餐时胰岛素

中文标题:

儿童及青少年特殊情况下住院高血糖管理指导建议

发布机构:

发布日期:

2020-10-30

简要介绍:

为了提高非内分泌专业儿科医师对儿童及青少年住院高血糖的科学管理能力,特制定本专家共识。在住院高血糖管理中,应坚持以不同病情人群为标准的分层血糖管理原则。胰岛素静脉输注和多次皮下注射(如基础‑餐时胰岛素)方案简明易懂,可操作性强,方便非内分泌专业儿科医生对相关科室患者及时处理,使血糖得以安全、有效地控制达标。以内分泌专业医师为核心,通过科室间会诊或网络技术等手段实时互动调整血糖管理方案的院内信息化血糖管理模式可以提高治疗效果、节省住院时间并减少院内交叉感染,推荐有条件的医疗单位积极摸索开展。

 

下载附件:

(因为版权问题,不支持下载)

评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1198132, encodeId=de17119813263, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcf45213614, createdName=14765a2cm38暂无昵称, createdTime=Mon Feb 28 20:07:39 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194648, encodeId=342a11946488d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:45:37 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060876, encodeId=45c410608e63c, content=真的挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75895311122, createdName=148898f3m13(暂无昵称), createdTime=Fri Oct 15 22:28:34 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006560, encodeId=611e100656009, content=积分。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/3210c6e9694d47ac9ce2af6815a912f0/5804ba1f1ae44cf5af0dc757813380eb.jpg, createdBy=ac715567493, createdName=ms9000000644420486, createdTime=Tue Aug 10 09:18:11 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909408, encodeId=ad4890940816, content=好建议!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 19 17:24:18 CST 2020, time=2020-12-19, status=1, ipAttribution=)]
    2022-02-28 14765a2cm38暂无昵称

    很好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1198132, encodeId=de17119813263, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcf45213614, createdName=14765a2cm38暂无昵称, createdTime=Mon Feb 28 20:07:39 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194648, encodeId=342a11946488d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:45:37 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060876, encodeId=45c410608e63c, content=真的挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75895311122, createdName=148898f3m13(暂无昵称), createdTime=Fri Oct 15 22:28:34 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006560, encodeId=611e100656009, content=积分。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/3210c6e9694d47ac9ce2af6815a912f0/5804ba1f1ae44cf5af0dc757813380eb.jpg, createdBy=ac715567493, createdName=ms9000000644420486, createdTime=Tue Aug 10 09:18:11 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909408, encodeId=ad4890940816, content=好建议!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 19 17:24:18 CST 2020, time=2020-12-19, status=1, ipAttribution=)]
    2022-02-18 1351fc2f66m

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1198132, encodeId=de17119813263, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcf45213614, createdName=14765a2cm38暂无昵称, createdTime=Mon Feb 28 20:07:39 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194648, encodeId=342a11946488d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:45:37 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060876, encodeId=45c410608e63c, content=真的挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75895311122, createdName=148898f3m13(暂无昵称), createdTime=Fri Oct 15 22:28:34 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006560, encodeId=611e100656009, content=积分。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/3210c6e9694d47ac9ce2af6815a912f0/5804ba1f1ae44cf5af0dc757813380eb.jpg, createdBy=ac715567493, createdName=ms9000000644420486, createdTime=Tue Aug 10 09:18:11 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909408, encodeId=ad4890940816, content=好建议!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 19 17:24:18 CST 2020, time=2020-12-19, status=1, ipAttribution=)]
    2021-10-15 148898f3m13(暂无昵称)

    真的挺好的

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1198132, encodeId=de17119813263, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcf45213614, createdName=14765a2cm38暂无昵称, createdTime=Mon Feb 28 20:07:39 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194648, encodeId=342a11946488d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:45:37 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060876, encodeId=45c410608e63c, content=真的挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75895311122, createdName=148898f3m13(暂无昵称), createdTime=Fri Oct 15 22:28:34 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006560, encodeId=611e100656009, content=积分。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/3210c6e9694d47ac9ce2af6815a912f0/5804ba1f1ae44cf5af0dc757813380eb.jpg, createdBy=ac715567493, createdName=ms9000000644420486, createdTime=Tue Aug 10 09:18:11 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909408, encodeId=ad4890940816, content=好建议!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 19 17:24:18 CST 2020, time=2020-12-19, status=1, ipAttribution=)]
    2021-08-10 ms9000000644420486

    积分。。。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1198132, encodeId=de17119813263, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcf45213614, createdName=14765a2cm38暂无昵称, createdTime=Mon Feb 28 20:07:39 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194648, encodeId=342a11946488d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:45:37 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060876, encodeId=45c410608e63c, content=真的挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75895311122, createdName=148898f3m13(暂无昵称), createdTime=Fri Oct 15 22:28:34 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006560, encodeId=611e100656009, content=积分。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/3210c6e9694d47ac9ce2af6815a912f0/5804ba1f1ae44cf5af0dc757813380eb.jpg, createdBy=ac715567493, createdName=ms9000000644420486, createdTime=Tue Aug 10 09:18:11 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909408, encodeId=ad4890940816, content=好建议!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 19 17:24:18 CST 2020, time=2020-12-19, status=1, ipAttribution=)]
    2020-12-19 jyzxjiangqin

    好建议!

    0

拓展阅读

2013中国成人住院患者高血糖管理目标专家共识

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2013-03-25

2015 ADA/EASD立场声明-2型糖尿病患者的高血糖管理:以患者为中心的治疗

美国糖尿病学会(ADA,American Diabetes Association) · 2014-12-20

中国高血糖危象诊断与治疗指南2013

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2016-04-27

2018 ADA/EASD共识:2型糖尿病患者高血糖的管理

美国糖尿病学会(ADA,American Diabetes Association) · 2018-10-04

2019 ADA/EASD共识:2型糖尿病患者高血糖的管理(更新版)

美国糖尿病学会(ADA,American Diabetes Association) · 2019-12-19

2021 ABCD 指南:成人糖尿病肾病高血糖管理的临床实践指南

英国临床糖尿病专家协会(ABCD,Association of British Clinical Diabetologists) · 2022-01-26